GlassScriptPhysician profile
Samira E Caraballo
NPI 1770134231
$5,097.30
in general payments reported to CMS, 2019-2025
7 companies · $207 in 2025
The $207 reported for 2025 was less than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14.91 · 2020: $2,287 · 2021: $432 · 2022: $712 · 2023: $933 · 2024: $512 · 2025: $207.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,651.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,651.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Musculoskeletal Transplant Foundation INC. | $2,411.81 | 2020-2021 | |
| Abbvie INC. | $1,636.27 | 2023-2025 | |
| Allergan, INC. | $934.22 | 2021-2022 | |
| Galderma Laboratories, L.P. | $42.17 | 2021-2024 | Dysport |
| Integra Lifesciences Corporation | $38.56 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $19.36 | 2021 | |
| Orthofix Medical, INC. | $14.91 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samira Caraballo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.